Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 33

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 33
---
 Alpha-Glucosidase
    Glycoprotein Processing Inhibitors 
    Pending 
    US 
    Pending 
      
    17/664,693# 
    19-Feb-2041^
  
    Treatment Of Human Coronavirus Infections Using Alpha-Glucosidase
    Glycoprotein Processing Inhibitors 
    Pending 
    EP 
    Pending 
      
    2021757552# 
    19-Feb-2041*
  
    Methods For The Treatment And Prevention Of Non-Viral Tick-Borne
    Diseases And Symptoms Thereof 
    Provisional 
    US 
    Provisional 
      
    63/461,060 
    ~21-Apr-2044&
  
    Methods To Treat Respiratory Infection Utilizing Castanospermine
    Analogs 
    Pending 
    US 
    Pending 
      
    18/218,202 
    05-Jul-2043^
  
    Methods To Treat Respiratory Infection Utilizing Castanospermine
    Analogs 
    Pending 
    PCT 
    Pending 
      
    PCT/US23/26884 
    05-Jul-2043*
  
    Methods For The Treatment And Prevention Of Diseases Or Infections
    With MCP-1 Involvement By Administration Of Tafenoquine 
    Pending 
    US 
    Pending 
      
    18/375,070 
    30-Sep-2043^
  
    Methods For The Treatment And Prevention Of Diseases Or Infections
    With MCP-1 Involvement By Administration Of Tafenoquine 
    Pending 
    PCT 
    Pending 
      
    PCT/US23/34169 
    30-Sep-2043
  
    Treatment Of Zika Virus Infections Using Alpha Glucosidase
    Inhibitors 
    10,328,061+ 
    US 
      
     6-25-2019 
    15/584,952+ 
    2-May-37
  
    Treatment Of Zika Virus Infections Using Alpha Glucosidase
    Inhibitors 
    10,561,642+ 
    US 
      
     2-18-2020 
    15/856,377+ 
    2-May-37

    * =
    For foreign patents and
    applications, the estimated and/or anticipated patent